Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1P44 is a processed pseudogene in humans, named eukaryotic translation elongation factor 1 alpha 1 pseudogene 44, and it is related to the functional EEF1A1 gene, which encodes a protein central to peptide elongation during translation[1][2][4]. Pseudogenes such as EEF1A1P44 are typically non-coding remnants of their parental gene and are usually not translated into functional proteins[2][4]. While some pseudogenes may produce short peptides or RNAs with regulatory roles, EEF1A1P44 has no reported biological functions, disease associations, or drug interactions[1][2][4]. There is no evidence supporting its use as a drug target, biomarker, or link to human disease[1][2][4]. It is simply recognized as one among many EEF1A1 pseudogenes present throughout the human genome[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 44 (EEF1A1P44).